Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VEEV Veeva Systems | ABT Abbott Laboratories |
|---|---|---|
| Price | $260.21 -1.3% | $102.61 +0.4% |
| StockIQ Score | 67B- Moderate Risk: Medium | 50C- Moderate Risk: Medium |
| Technical | 64C+ | 19F |
| Fundamental | 76B+ | 72B |
| Growth | 71B | 45D+ |
| Fair Value | 45D+ | 38F |
| News | 98A+ | 98A+ |
| Quality | 58C | 63C+ |
| Risk | 48D+ | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Veeva Systems (VEEV) outperforms Abbott Laboratories (ABT) in nearly every category. Its technical score (86 vs. 50) and overall investor rating ("STRONG" vs. "MODERATE") are significantly stronger. VEEV also leads in growth (71 vs. 45), though ABT has a slightly higher fundamental score (72 vs. 76). Valuation is weaker for VEEV (45 vs. 38).